2L. De Angelis,M. A. Marfella,M. Siniscalchi,L. Marino,F. Nappo,F. Giugliano,D. De Lucia,D. Giugliano. Erectile and endothelial dysfunction in Type II diabetes: a possible link[J] 2001,Diabetologia(9):1155～1160
3E. B. Jude,C. A. Abbott,M. J. Young,S. G. Anderson,J. T. Douglas,A. J. M. Boulton. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy[J] 1998,Diabetologia(3):330～336
4K. Hirata,K. Shikata,M. Matsuda,K. Akiyama,H. Sugimoto,M. Kushiro,H. Makino. Increased expression of selectins in kidneys of patients with diabetic nephropathy[J] 1998,Diabetologia(2):185～192
二级参考文献12
1[1]Fuller JH, Shipley M J, Rose G, et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the whitehall study. Br Med J, 1983, 287:867-870.
2[2]Strano A, Davi G, Patrono C. In vivo platelet activation in diabetes mellitus. Serm Thromb Haemost, 1991, 17: 422-430.
3[3]Wang X, Wei W, Wang H. Laboratory techniques of molecular markers. In: Wang Z, Li G, Ruan C, eds. Thrombosis and haemostasis. Basic principles and clinic. Shanghai Science-technique Press, 1996, 668-673.
4[4]Catella F, Healy D, Lawson JA, et al. 11-dehydro-thromboxane B2:a quantitative index of thronboxane A2 formation in the human circulation. Proc Natl Acad Sci USA, 1986, 83:5861-5865.
5[5]Wang Z, Chen D, He Y, et al. 125 I-labeled radioimmunoassay for thromboxane B2. Suzhou Academia Acta, 1986, 6: 13-15.
6[6]Wang Z, Wang S, Ruan C. Measurement of 11-dehydro-thromboxane B2 and its clinical significance. Chin J Haematol, 1996, 17: 472-475.
7[7]Shattil SHJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 1987, 70: 307-314.
8[8]Wu G, Ruan C. Measurement of platelet granule membrane protein using 125I-labeled monoclonal antibodies. Chin J Nucl Med, 1993, 13:46-48.
9[9]Zhao Y, He Y, Shen W, et al. Plasma P-selectin measurement using the ERMA method and its clinical significance. J Exp Haematol,1997, 5: 426-428.
10[10]Gresele P, Catalano M, Giammarresi C, et al. Flatelet activation markers in patients with peripheral arterial disease. Thromb Haemost, 1997, 87: 1434-1438.
